Remus Pharmaceuticals Limited is informing the National Stock Exchange of India that it is exempt from filing a quarterly/half yearly/yearly Corporate Governance Report as per Regulation 27(2) of the SEBI (Listing Obligations and Disclosure Requirements), 2015.